| MIR224 |
|
microRNA 224
|
|
|
0.534 |
0.654 |
| MIR99A |
|
microRNA 99a
|
|
|
0.536 |
0.808 |
| HLA-DRB3 |
P79483
|
major histocompatibility complex, class II, DR beta 3
|
Immune response
|
|
0.570 |
0.885 |
| HCP5 |
Q6MZN7
|
HLA complex P5
|
|
|
0.595 |
0.808 |
| KIR2DS2 |
P43631
|
killer cell immunoglobulin like receptor, two Ig domains and short cytoplasmic tail 2
|
|
|
0.599 |
0.615 |
| MIR196A1 |
|
microRNA 196a-1
|
|
|
0.599 |
0.577 |
| KIR2DL2 |
P43627
|
killer cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 2
|
Receptor
|
|
0.612 |
0.654 |
| SERPINA13P |
Q6UXR4
|
serpin family A member 13, pseudogene
|
|
|
0.619 |
0.692 |
| HCC |
|
thyroid carcinoma, Hurthle cell
|
|
|
0.644 |
0.423 |
| H3P44 |
|
H3 histone pseudogene 44
|
|
|
0.636 |
0.462 |
| GER |
|
Gastroesophageal reflux
|
|
|
0.678 |
0.538 |
| IFNL4 |
K9M1U5
|
interferon lambda 4 (gene/pseudogene)
|
|
|
0.670 |
0.577 |
| CYCSP25 |
|
CYCS pseudogene 25
|
|
|
0.780 |
0.231 |
| REXO1L1P |
Q8IX06
|
REXO1 like 1, pseudogene
|
Enzyme
|
|
0.792 |
0.077 |
| IFNA4 |
P05014
|
interferon alpha 4
|
|
|
0.861 |
0.154 |
| CD36 |
P16671
|
CD36 molecule
|
Receptor
|
1.1E-60 |
0.446 |
0.846 |
| ABCC2 |
Q92887
|
ATP binding cassette subfamily C member 2
|
Transporter
|
5.2E-47 |
0.483 |
0.808 |
| IFIH1 |
Q9BYX4
|
interferon induced with helicase C domain 1
|
|
7.0E-44 |
0.471 |
0.808 |
| CR1 |
P17927
|
complement C3b/C4b receptor 1 (Knops blood group)
|
|
1.6E-35 |
0.533 |
0.808 |
| SLC28A2 |
O43868
|
solute carrier family 28 member 2
|
Transporter
|
1.1E-27 |
0.780 |
0.385 |
| VIPR1 |
P32241
|
vasoactive intestinal peptide receptor 1
|
G-protein coupled receptor
|
7.4E-27 |
0.573 |
0.654 |
| CYP2D6 |
P10635
|
cytochrome P450 family 2 subfamily D member 6
|
|
1.1E-25 |
0.437 |
0.885 |
| LDLR |
P01130
|
low density lipoprotein receptor
|
|
9.8E-24 |
0.449 |
0.885 |
| DDX58 |
O95786
|
DExD/H-box helicase 58
|
|
1.8E-23 |
0.526 |
0.808 |
| NOTCH4 |
Q99466
|
notch receptor 4
|
|
2.1E-23 |
0.534 |
0.731 |